Norwich Clinical Research: Press Releases

FDA Approves Beech Tree Labs' Recurrent Oral Herpes Infections IND Application - Another Successful Collaboration Milestone for NCRA and BTL
Monday, July 26, 2010 by Norwich Clinical Research Beech Tree Labs has announced that the FDA has approved its IND for a Phase 1/2a clinical evaluation of BTL-TML-HSV, a novel therapeutic agent for treating recurrent oral herpes infections....

Investigator Responsibilities Revisited by FDA
Monday, March 29, 2010 by Norwich Clinical Research By Glenda Guest, vice president, Norwich Clinical Research Associates (NCRA) While the title of the new guidance from FDA is 'Investigator Responsibilities', in reality sponsors also...

FDA Approves Beech Tree Labs' Influenza IND Application
Friday, January 29, 2010 by Norwich Clinical Research Beech Tree Labs, Inc., has announced that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza...